MiMedx Group, Inc. has recently disclosed in a Schedule 13G filing that Trigran Investments, Inc. has acquired a 5.1% stake in the company. This move is noteworthy as it may indicate potential changes in the company’s governance and strategic direction.
MiMedx Group, Inc., classified under the SIC code 3841, specializes in surgical and medical instruments and apparatus. The company is publicly traded on the Nasdaq under the ticker MDXG. The recent filing is part of a series of disclosures made by the company, including a 10-Q and an 8-K, filed on October 28, 2026, and a previous Schedule 13G filed on November 12, 2026.
The Schedule 13G filing indicates that Trigran Investments, Inc., based in Northbrook, Illinois, holds a total of 7,391,329 shares of MiMedx common stock, with shared voting power of 6,753,733 shares. The filing also notes that the reporting persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest.
This acquisition by Trigran Investments may affect various stakeholders, including shareholders and management at MiMedx, as well as competitors in the surgical and medical instruments industry. The presence of a significant investor like Trigran could lead to increased scrutiny of MiMedx's operational strategies and performance.
Looking ahead, the filing does not specify what actions may follow this acquisition. Stakeholders will be keen to see how this change in ownership influences MiMedx's future direction and market strategies.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





